Affordable Access

Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders.

Authors
Type
Published Article
Journal
Haematologica
1592-8721
Publisher
Ferrata Storti Foundation
Publication Date
Volume
89
Issue
5
Pages
520–527
Identifiers
PMID: 15136214
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments